Daily funding roundup - November 7th, 2019

FamePick raised $4.6M; CrowdStreet landed $12M; Healthify and SquareFoot closed $16M

FamePick: FamePick is a platform for business-minded creators. FamePick raised $4.6m in Series A funding. The round was led by InterVest and individuals including Guitar Hero co-founder Kai Huang, Sendbird co-founder John Kim, Kakao co-founder Jaebum Lee, and former CSO of SK Planet Inc. Woo Park. Venture firms Mirae Asset Venture, Aju IB Investment, and DVP also participated in the round. Read more

CrowdStreet: CrowdStreet brings together accredited investors and real estate developers online, using technology to open up the commercial real estate marketplace. CrowdStreet raised $12 million Series C round of funding, but that only $3 million of it came from traditional institutional investors, including previous investors Grotech Ventures, Rally Ventures, Seven Peaks Ventures, and Green Visor Capital. Read more

Healthify: Healthify is the company that is building out framework in order to allow payers, providers and social service organizations to communicate with each other so that they know that people are actually getting access to the services that they need. Healthify has raised $16 million in Series B funding in a round led by SV Health Investors and existing investors like BlueCross BlueShield Venture Partners (BCBSVP). Read more

SquareFoot: SquareFoot is a real estate broker for companies (under 70 employees typically) seeking office space, specifically in New York, downtown Houston and some other major cities. SquareFoot has raised $16 million Series B funding round, led by DRW VC, which includes existing investors, Triangle Peak Partners, RRE, and Rosecliff Ventures. Read more

Productiv: Productiv, the application engagement analytics company, today announced the close of $20M in Series B financing led by Norwest Venture Partners with additional participation from strategic investor Okta Ventures and existing investor Accel. Read more

Mission Bio: Mission Bio’s mission is to help researchers and clinicians unlock single-cell biology to enable the discovery, development, and delivery of precision medicine. Mission Bio has raised $30 million in a Series B financing round led by Agilent Technologies, Cota Capital, LAM Capital, and Mayfield, bringing its total financing to more than $50 million. Read more

If you are interested in being included in our funding roundup, submit your press release or blog post about your financing round to kristin@vator.tv. If you want a longer write-up, please do give us a couple of days heads up. If you'd like to be included in our Today's Entrepreneur column, please send me your Vator profile.

Image source: pixabay.com